AccScience Publishing / EJMO / Online First / DOI: 10.36922/EJMO026030030
ORIGINAL RESEARCH ARTICLE

Intervertebral disc degeneration and generalized anxiety disorder: A bidirectional two-sample Mendelian randomization study

Wei Zhang1† Jiantong Wei1,2† Shenggang Xu3 Ying Cao1 Xiaomei Yang1*
Show Less
1 Department of Orthopedics, Zhangye People’s Hospital Affiliated to Hexi University, Zhangye, Gansu, China
2 Frontier Innovation Research Center, First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China
3 Department of Public Health, Medical College of Hexi University, Zhangye, Gansu, China
†These authors contributed equally to this work.
Received: 15 January 2026 | Revised: 9 February 2026 | Accepted: 24 February 2026 | Published online: 29 April 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC-by the license) ( https://creativecommons.org/licenses/by-nc/4.0/ )
Abstract

Introduction: The co-occurrence of chronic musculoskeletal conditions and psychiatric disorders is clinically significant; however, the causal direction between intervertebral disc degeneration (IVDD) and generalized anxiety disorder (GAD) remains poorly defined.

Objective: To evaluate the bidirectional causal association between IVDD and GAD using Mendelian randomization (MR).

Methods: Leveraging aggregate statistics from extensive genome-wide association study (GWAS) datasets, we performed a two-sample bidirectional MR investigation. Genetic proxies serving as instrumental variables (IVs) were identified using stringent filtering criteria, including a significance threshold of p < 5 × 10−8, and the exclusion of linkage disequilibrium (r2 < 0.001, distance > 10,000 kb). The primary causal effect was quantified using inverse variance-weighted (IVW) regression, while robustness of the estimates was cross-validated using MR-Egger, weighted median, and model-based estimators. To ensure the integrity of the inference, we performed sensitivity diagnostics, including Cochran’s Q test for heterogeneity, the MR-Egger intercept for directional pleiotropy, and leave-one-out analysis for individual single-nucleotide polymorphism stability.

Results: In the forward-direction analysis, a genetic predisposition to IVDD was correlated with an increased risk of GAD, as confirmed by both the IVW model (odds ratio [OR] = 1.198, 95% confidence interval [CI]: 1.069–1.343, p = 0.002) and the weighted median method (OR = 1.193, 95% CI: 1.024–1.389, p = 0.023). In contrast, no statistically significant causal influence of GAD on the risk of IVDD was observed (p > 0.05). Comprehensive sensitivity analyses confirmed that the selected IVs satisfied the core MR assumptions. Furthermore, diagnostic tests revealed no evidence of substantial heterogeneity (Q p-value = 0.098) or significant bias stemming from horizontal pleiotropy (Egger intercept p-value = 0.568).

Conclusion: Bidirectional MR analysis supports a unidirectional causal relationship from IVDD to GAD, underscoring the importance of routine anxiety screening and targeted psychological interventions in patients with spinal degeneration to mitigate subsequent psychiatric deterioration.

Keywords
Intervertebral disc degeneration
Generalized anxiety disorder
Mendelian randomization
Causality
Funding
This project was supported by the Hexi University President’s Fund for Innovative Research Teams (CXTD002, 2022), the Hexi University President’s Fund for Young Researchers (QN2024031, 2024), the Gansu Provincial Health and Health Industry Science and Technology Innovation Major Research Project (GSWSQN2024-21, 2024), and the Gansu Provincial Science and Technology Plan Funding Project (25JRRG006, 2025), and the Gansu Provincial Department of Education Industrial Support Program Project (2025CYZC-061, 2025).
Conflict of interest
The authors have no conflicts of interest to disclose.
References
  1. Szuhany KL, Simon NM. Anxiety disorders: a review. JAMA. 2022;328(24):2431-2445. doi: 10.1001/jama.2022.22744

 

  1. Munir S, Takov V, Coletti VA. Generalized anxiety disorder (nursing). In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih. gov/books/NBK568696/ [Last accessed on 17 October 2022]

 

  1. Fagan HA, Baldwin DS. Pharmacological treatment of generalised anxiety disorder: current practice and future directions. Expert Rev Neurother. 2023;23(6):535-548. doi: 10.1080/14737175.2023.2211767

 

  1. Trenoska Basile V, Newton-John T, Wootton BM. Remote cognitive-behavioral therapy for generalized anxiety disorder: a preliminary meta-analysis. J Clin Psychol. 2022;78(12):2381-2395. doi: 10.1002/jclp.23360

 

  1. DeGeorge KC, Grover M, Streeter GS. Generalized anxiety disorder and panic disorder in adults. Am Fam Physician. 2022;106(2):157-164. PMID: 35977134

 

  1. Newman MG, Basterfield C, Erickson TM, Caulley E, Przeworski A, Llera SJ. Psychotherapeutic treatments for generalized anxiety disorder: cognitive and behavioral therapies, enhancement strategies, and emerging efforts. Expert Rev Neurother. 2022;22(9):751-770. doi: 10.1080/14737175.2022.2125800

 

  1. Ruscio AM, Hallion LS, Lim CCW, et al. Cross-sectional comparison of the epidemiology of DSM-5 generalized anxiety disorder across the globe. JAMA Psychiatry. 2017;74(5):465-475. doi: 10.1001/jamapsychiatry.2017.0056

 

  1. Dursun P, Alyagut P, Yılmaz I. Meaning in life, psychological hardiness and death anxiety: individuals with or without generalized anxiety disorder (GAD). Curr Psychol. 2022;41(6):3299-3317. doi: 10.1007/s12144-021-02695-3

 

  1. Moreno-Peral P, Conejo-Cerón S, Motrico E, et al. Risk factors for the onset of panic and generalised anxiety disorders in the general adult population: a systematic review of cohort studies. J Affect Disord. 2014;168:337-348. doi: 10.1016/j.jad.2014.06.021

 

  1. Bandelow B. Generalized anxiety disorder and pain. Mod Trends Pharm. 2015;30:153-165. doi: 10.1159/000435939

 

  1. Meng J, Zhang T, Hao T, et al. Functional and structural abnormalities in the pain network of generalized anxiety disorder patients with pain symptoms. Neuroscience. 2024;543:28-36. doi: 10.1016/j.neuroscience.2024.02.006

 

  1. Guo W, Li BL, Zhao JY, Li XM, Wang LF. Causal associations between modifiable risk factors and intervertebral disc degeneration. Spine J. 2024;24(2):195-209. doi: 10.1016/j.spinee.2023.10.021

 

  1. Knezevic NN, Candido KD, Vlaeyen JWS, Van Zundert J, Cohen SP. Low back pain. Lancet. 2021;398(10294):78-92. doi: 10.1016/S0140-6736(21)00733-9

 

  1. Hu Y, Yang Z, Li Y, Xu Y, Zhou X, Guo N. Anxiety symptoms and associated factors among chronic low back pain patients in China: a cross-sectional study. Front Public Health. 2022;10:878865. doi: 10.3389/fpubh.2022.878865

 

  1. Singhal K, Muliyala KP, Pakhare AP, Behera P, Santoshi JA. Do patients of chronic low back pain have psychological comorbidities? Avicenna J Med. 2021;11(3):145-151. doi: 10.1055/s-0041-1734385

 

  1. Janzen K, Peters-Watral B. Treating co-occurring chronic low back pain & generalized anxiety disorder. Nurse Pract. 2016;41(1):12-18. doi: 10.1097/01.NPR.0000475373.08924.04

 

  1. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9

 

  1. Kao YC, Chen JY, Chen HH, Liao KW, Huang SS. The association between depression and chronic lower back pain from disc degeneration and herniation of the lumbar spine. Int J Psychiatry Med. 2022;57(2):165-177. doi: 10.1177/00912174211003760

 

  1. Nasyrova R, Novitsky M, Shnayder N, et al. Incidence of anxiety and depression in adult patients with chronic discogenic back pain. Psychiatr Danub. 2024;36(2):155-159. PMID: 39378464

 

  1. Ni J, Zhou W, Cen H, et al. Evidence for causal effects of sleep disturbances on risk for osteoarthritis: a univariable and multivariable Mendelian randomization study. Osteoarthr Cartil. 2022;30(3):443-450. doi: 10.1016/j.joca.2021.11.021

 

  1. Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601. doi: 10.1136/bmj.k601

 

  1. Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: a review. Res Synth Methods. 2019;10(4):486- 496. doi: 10.1002/jrsm.1346

 

  1. Kurki MI, Karjalainen J, Palta P, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508-518. doi: 10.1038/s41586-022-05473-8

 

  1. Burgess S, Davey Smith G, Davies NM, et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res. 2023;4:186. doi: 10.12688/wellcomeopenres.15555.3

 

  1. Pierce BL, Burgess S. Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol. 2013;178(7):1177-1184. doi: 10.1093/aje/kwt084

 

  1. Ouyang Y, Dai M. Anxiety disorders and adhesive capsulitis: a bidirectional Mendelian randomization study. Front Immunol. 2023;14:1297477. doi: 10.3389/fimmu.2023.1297477

 

  1. Ference BA, Holmes MV, Smith GD. Using Mendelian randomization to improve the design of randomized trials. Cold Spring Harb Perspect Med. 2021;11(7):a040634. doi: 10.1101/cshperspect.a040980

 

  1. Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693-698. doi: 10.1038/s41588-018-0099-7

 

  1. Sang D, Xiao B, Rong T, et al. Depression and anxiety in cervical degenerative disc disease: who are susceptible? Front Public Health. 2023;10:1002837. doi: 10.3389/fpubh.2022.1002837

 

  1. Kregel J, Meeus M, Malfliet A, et al. Structural and functional brain abnormalities in chronic low back pain: a systematic review. Semin Arthritis Rheum. 2015;45(2):229-237. doi: 10.1016/j.semarthrit.2015.05.002

 

  1. Li W, Gong Y, Liu J, et al. Peripheral and central pathological mechanisms of chronic low back pain: a narrative review. J Pain Res. 2021;14:1483-1494. doi: 10.2147/JPR.S306280

 

  1. Kang L, Zhang H, Jia C, Zhang R, Shen C. Epigenetic modifications of inflammation in intervertebral disc degeneration. Ageing Res Rev. 2023;87:101902. doi: 10.1016/j.arr.2023.101902

 

  1. Kéri S, Kancsev A, Kelemen O. Algorithm-based modular psychotherapy alleviates brain inflammation in generalized anxiety disorder. Life. 2024;14(7):887. doi: 10.3390/life14070887

 

  1. Zainal NH, Newman MG. Inflammation mediates depression and generalized anxiety symptoms predicting executive function impairment after 18 years. J Affect Disord. 2022;296:465-475. doi: 10.1016/j.jad.2021.08.077

 

  1. Zhang X, Norton J, Carrière I, et al. Preliminary evidence for a role of the adrenergic nervous system in generalized anxiety disorder. Sci Rep. 2017;7(1):42676. doi: 10.1038/srep42676

 

  1. Carnevali L, Mancini M, Koenig J, et al. Cortical morphometric predictors of autonomic dysfunction in generalized anxiety disorder. Auton Neurosci. 2019;217:41- 48. doi: 10.1016/j.autneu.2019.01.001

 

  1. Ma Z, Zhao M, Zhao H, Qu N. Causal role of immune cells in generalized anxiety disorder: Mendelian randomization study. Front Immunol. 2024;14:1338083. doi: 10.3389/fimmu.2023.1338083

 

  1. van Vuuren BJ, van Heerden HJ, Becker PJ, Zinzen E, Meeusen R. Fear-avoidance beliefs and pain coping strategies in relation to lower back problems in a South African steel industry. Eur J Pain. 2006;10(3):233-239. doi: 10.1016/j.ejpain.2005.03.012

 

  1. Cherkin DC, Sherman KJ, Balderson BH, et al. Effect of mindfulness-based stress reduction vs cognitive behavioral therapy or usual care on back pain and functional limitations in adults with chronic low back pain: a randomized clinical trial. JAMA. 2016;315(12):1240-1249. doi: 10.1001/jama.2016.2323

 

  1. Menear M, Girard A, Dugas M, Gervais M, Gilbert M, Gagnon MP. Personalized care planning and shared decision making in collaborative care programs for depression and anxiety disorders: a systematic review. PLoS ONE. 2022;17(6):e0268649. doi: 10.1371/journal.pone.0268649

 

  1. Archer J, Bower P, Gilbody S, et al. Collaborative care for depression and anxiety problems. Cochrane Database Syst Rev. 2012;10(10):CD006525. doi: 10.1002/14651858.CD006525.pub2
Share
Back to top
Eurasian Journal of Medicine and Oncology, Electronic ISSN: 2587-196X Print ISSN: 2587-2400, Published by AccScience Publishing